Business Description
Alar Pharmaceuticals Inc
ISIN : TW0006785009
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5717.9 | |||||
Equity-to-Asset | 0.98 | |||||
Interest Coverage | 11346.18 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 103.02 | |||||
Beneish M-Score | 260.75 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 781.7 | |||||
3-Year Book Growth Rate | 14.4 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.35 | |||||
9-Day RSI | 41.08 | |||||
14-Day RSI | 39.78 | |||||
6-1 Month Momentum % | -38.71 | |||||
12-1 Month Momentum % | -26.92 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 45.14 | |||||
Quick Ratio | 45.14 | |||||
Cash Ratio | 44.92 | |||||
Days Sales Outstanding | 0.65 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.07 | |||||
Dividend Payout Ratio | 0.21 | |||||
Forward Dividend Yield % | 1.07 | |||||
5-Year Yield-on-Cost % | 1.08 | |||||
Shareholder Yield % | -16.71 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 99.57 | |||||
Operating Margin % | 81.34 | |||||
Net Margin % | 84.49 | |||||
FCF Margin % | 45.91 | |||||
ROE % | 22.46 | |||||
ROA % | 21.36 | |||||
ROIC % | 345.82 | |||||
ROC (Joel Greenblatt) % | 3236.55 | |||||
ROCE % | 23.56 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 19.95 | |||||
Forward PE Ratio | 381.08 | |||||
PE Ratio without NRI | 19.95 | |||||
PS Ratio | 16.98 | |||||
PB Ratio | 3.82 | |||||
Price-to-Tangible-Book | 3.82 | |||||
Price-to-Free-Cash-Flow | 35.09 | |||||
Price-to-Operating-Cash-Flow | 34.73 | |||||
EV-to-EBIT | 16.6 | |||||
EV-to-EBITDA | 16.45 | |||||
EV-to-Revenue | 14.75 | |||||
EV-to-FCF | 32.12 | |||||
Price-to-Graham-Number | 1.84 | |||||
Price-to-Net-Current-Asset-Value | 3.96 | |||||
Price-to-Net-Cash | 3.98 | |||||
Earnings Yield (Greenblatt) % | 6.02 | |||||
FCF Yield % | 2.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Alar Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 474.289 | ||
EPS (TTM) (NT$) | 7.068 | ||
Beta | 0.84 | ||
Volatility % | 88.02 | ||
14-Day RSI | 39.78 | ||
14-Day ATR (NT$) | 5.694729 | ||
20-Day SMA (NT$) | 146.825 | ||
12-1 Month Momentum % | -26.92 | ||
52-Week Range (NT$) | 135 - 465 | ||
Shares Outstanding (Mil) | 66.8 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Alar Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Alar Pharmaceuticals Inc Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Alar Pharmaceuticals Inc Frequently Asked Questions
What is Alar Pharmaceuticals Inc(ROCO:6785)'s stock price today?
When is next earnings date of Alar Pharmaceuticals Inc(ROCO:6785)?
Does Alar Pharmaceuticals Inc(ROCO:6785) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |